Intraoperative radiotherapy for breast cancer

被引:143
作者
Vaidya, JS
Tobias, JS
Baum, M
Keshtgar, M
Joseph, D
Wenz, F
Houghton, J
Saunders, C
Corica, T
D'Souza, D
Sainsbury, R
Massarut, S
Taylor, I
Hilaris, B
机构
[1] Royal Free & Univ Coll Med Sch, Dept Surg, Clin Trials Grp, London W1W 7EJ, England
[2] UCL, London, England
[3] Middlesex Hosp, Myerstein Inst Oncol, London, England
[4] Sir Charles Gairdner Hosp, Perth, WA, Australia
[5] Univ Mannheim, D-6800 Mannheim 1, Germany
[6] Ctr Riferimento Oncol, I-33081 Aviano, Italy
[7] New York Med Coll, Our Lady Mercy Med Ctr, Valhalla, NY 10595 USA
关键词
D O I
10.1016/S1470-2045(04)01412-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Postoperative radiotherapy, which forms part of breast-conserving therapy, may not need to encompass the whole breast. Apart from the consumption of huge resources and patients' time, postoperative radiotherapy deters many women from receiving the benefits of breast-conserving surgery, forcing them to choose a mastectomy instead. If radiotherapy could be given in the operating theatre immediately after surgery, many of these disadvantages could be overcome. One striking fact about local recurrence after breast-conserving surgery is that most occurs in the area of breast immediately next to the primary tumour; this is despite the finding that two-thirds of mastectomy samples have microscopic tumours distributed throughout the breast, even when radiotherapy is omitted. Thus, only the area adjacent to the tumour may need treatment with radiotherapy. On the basis of this premise, clinical scientists have used new technology to administer radiotherapy to the area at greatest risk of local recurrence, with the aim of completing the whole local treatment in one sifting. In this review, we have elaborated on the rationale and different methods of delivery of intraoperative radiotherapy. If this approach is validated by the results of current randomised trials, it could save time, money, and breasts.
引用
收藏
页码:165 / 173
页数:9
相关论文
共 55 条
[31]  
Perera F, 1997, J SURG ONCOL, V65, P263, DOI 10.1002/(SICI)1096-9098(199708)65:4<263::AID-JSO7>3.0.CO
[32]  
2-3
[33]   Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer:: Five-year results of a phase I-II study and initial findings of a randomized phase III trial [J].
Polgár, C ;
Sulyok, Z ;
Fodor, J ;
Orosz, Z ;
Major, T ;
Takácsi-Nagy, Z ;
Mangel, LC ;
Somogyi, A ;
Kásler, M ;
Németh, G .
JOURNAL OF SURGICAL ONCOLOGY, 2002, 80 (03) :121-128
[34]  
Polgár C, 2002, STRAHLENTHER ONKOL, V178, P597, DOI 10.1007/s00066-002-0966-z
[35]  
Ribeiro G G, 1993, Clin Oncol (R Coll Radiol), V5, P278, DOI 10.1016/S0936-6555(05)80900-8
[36]   A pilot study of radical radiotherapy using a perioperative implant following wide local excision for carcinoma of the breast [J].
Samuel, LM ;
Dewar, JA ;
Preece, PE ;
Wood, RAB .
BREAST, 1999, 8 (02) :95-97
[37]  
SCHNITT SJ, 1984, CANCER, V53, P1049, DOI 10.1002/1097-0142(19840301)53:5<1049::AID-CNCR2820530506>3.0.CO
[38]  
2-O
[39]   Quality assurance in breast cancer brachytherapy: Geographic miss in the interstitial boost treatment of the tumor bed [J].
Sedlmayer, F ;
Rahim, HBK ;
Kogelnik, HD ;
Menzel, C ;
Merz, F ;
Deutschmann, H ;
Kranzinger, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 34 (05) :1133-1139
[40]   Temporal CT changes after hepatic and renal interstitial radiotherapy in a canine model [J].
Solomon, SB ;
Koniaris, LG ;
Chan, DY ;
Magee, CA ;
DeWeese, TL ;
Kavoussi, LR ;
Choti, MA .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2001, 25 (01) :74-80